Cubresa to exhibit innovative Spark preclinical SPECT scanner at SNMMI
Cubresa today announced it will debut its novel Spark preclinical SPECT scanner at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 8 – June 10th in St. Louis, Missouri. Attendees are invited to visit booth #503 in the exhibition hall to learn more about the product. The Spark SPECT scanner for…
Cubresa Announces New Compact SPECT Scanner for Preclinical Imaging Research
A fast and affordable way to add SPECT to an existing small animal CT scanner WINNIPEG, Manitoba – April 16th, 2014 – Today Cubresa introduced a new compact, affordable SPECT scanner for preclinical research. The scanner attaches to existing small animal CT systems, transforming them into multi-modality molecular imaging systems for disease study, translational research…
September 21, 2013
Cubresa Moves to Larger Premises
Cubresa today announced that it has moved to larger office and manufacturing space at 1393 Border Street in Winnipeg, Manitoba, Canada. “This increased space is a testament to our advancing relationship with our customers and the investment that we are receiving from our community” said James Schellenberg, CEO and Founder of Cubresa.
June 27, 2013
Cubresa Receives Series A Investment
Cubresa today announced that it has received investment from the Manitoba Knights. The $500,000 Series A investment will be used to support the development of a compact SPECT imager for the preclinical imaging market.
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
Company
About Us
Leadership
Technology
Careers
Location
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4
Products
Clinical:
Preclinical:
Contact
Request more information